Crossref
Community Oncologists’ Perception and Acceptance of Biosimilars in Oncology
Journal of Clinical Pathways · 2018
DOI: 10.25270/jcp.2018.03.00005 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Clinical Pathways, 2018. Verfasst von Chadi Nabhan und 3 weiteren Autor:innen. Die Arbeit wurde bisher 11-mal zitiert (Crossref).
Abstract (Originalsprache)
Kein Abstract verfügbar.
Zitieren
APA
Nabhan, C., Jeune-Smith, Y., Valley, A., & Feinberg, B. A. (2018). Community Oncologists’ Perception and Acceptance of Biosimilars in Oncology. Journal of Clinical Pathways. https://doi.org/10.25270/jcp.2018.03.00005
Vancouver
Nabhan C, Jeune-Smith Y, Valley A, Feinberg BA. Community Oncologists’ Perception and Acceptance of Biosimilars in Oncology. Journal of Clinical Pathways. 2018. doi:10.25270/jcp.2018.03.00005
BibTeX
@article{Nabhan2018,
author = {Nabhan, Chadi and Jeune-Smith, Yolaine and Valley, Amy and Feinberg, Bruce A},
title = {Community Oncologists’ Perception and Acceptance of Biosimilars in Oncology},
journal = {Journal of Clinical Pathways},
year = {2018},
doi = {10.25270/jcp.2018.03.00005}
}
EUVIMED